Search Browse Earnings

Janux Therapeutics, Inc. — SlamSEC

Janux Therapeutics, Inc.

Nasdaq:JANX

Pharmaceutical Preparations·SAN DIEGO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$8.1M

-6.1% YoY

FY 2025

Adj. EBITDA

-$71.0M

-878.7% margin

FY 2025

Net Income

-$58.3M

-721.2% margin

FY 2025

EPS (Diluted)

-$1.32

FY 2025

Stock Price

$14.04

-0.2%

2026-03-12

52W Range

$12.12 – $35.34

P/E Ratio

-10.6x

Market Cap

$854.1M

Cash

$430.6M

FY 2025

Total Debt

—

Net Cash

$430.6M

FY 2025

Enterprise Value

$423.5M

Debt / EBITDA

6.1x

FY 2025

EV / EBITDA

-6.0x

Employees

—